Curated News:

NEJM

Add to Favorites Subscribe Share
fbshare-NEJM

Showing results

110 of 332
  • Embargo expired:
    21-Aug-2019 5:00 PM EDT

Article ID: 717580

Unprecedented Therapy Found Effective for Blood Cancer Patients With No Treatment Options

Mount Sinai Health System

Mount Sinai researchers have found a new type of therapy to be effective for patients with a particular type of bone marrow cancer that is resistant to several standard therapies, according to results of a clinical trial published in The New England Journal of Medicine in August.

Released:
16-Aug-2019 11:00 AM EDT
Signature-Vertical.png
  • Embargo expired:
    14-Aug-2019 5:00 PM EDT

Article ID: 717251

Surgeons report success in reducing opioid prescribing without increasing patients’ pain

Michigan Medicine - University of Michigan

A new study shows how one state’s surgeons reduced the number of opioids they prescribed to thousands of patients -- without causing patients to feel more pain or less satisfied with their surgical experience.

Released:
9-Aug-2019 10:30 AM EDT
HSC-1489-NewsHeader-1200w.png

Article ID: 717142

Promising Clinical Trial Results for Drug for Rare Disease in Which Patients Can’t Eat Fat

University of California San Diego Health

In a Phase III clinical trial, the drug volanesorsen significantly reduced blood fat (triglyceride) levels in participants with a rare disease called familial chylomicronemia syndrome; finding could also help inform better prevention methods and treatments for many types of heart disease.

Released:
8-Aug-2019 4:25 AM EDT
UH_Cleveland_RGB.jpg
  • Embargo expired:
    31-Jul-2019 5:05 PM EDT

Article ID: 716559

Physician Leaders Call for Action to Create a New Generation of Physician-Scientists

University Hospitals Cleveland Medical Center

In a perspective article in the New England Journal of Medicine, a group of prominent physician-scientist leaders proposes a plan for increasing the number of physicians who conduct research looking for tomorrow’s breakthroughs and cures. They write, “Revitalizing the physician-scientist pipeline is of critical importance to overcoming current and future health challenges.”

Released:
29-Jul-2019 4:00 PM EDT
UCSF_Diller_navy_RGB_2_1.jpg

Article ID: 716753

Scientists Discover Autoimmune Disease Associated with Testicular Cancer

UCSF Helen Diller Family Comprehensive Cancer Center

Using advanced technology, scientists at Chan Zuckerberg (CZ) Biohub, Mayo Clinic and UC San Francisco, have discovered an autoimmune disease that appears to affect men with testicular cancer.

Released:
31-Jul-2019 4:05 PM EDT
  • Embargo expired:
    24-Jul-2019 5:00 PM EDT

Article ID: 716231

Targeted therapy erdafitinib effective for patients with advanced bladder cancer and specific gene mutations

University of Texas M. D. Anderson Cancer Center

A Phase II clinical trial led by MD Anderson found that treatment with the FGFR inhibitor erdafitinib was effective in 40% of patients with metastatic bladder cancers marked by FGFR3 mutations. The trial results led to FDA approval of the drug.

Released:
23-Jul-2019 5:00 PM EDT
hms-logo.gif
  • Embargo expired:
    17-Jul-2019 5:00 PM EDT

Article ID: 715716

Sustainable Savings on Medical Care

Harvard Medical School

Over eight years, patients covered under a global budget payment model for doctors and hospitals showed slower spending growth and better quality than comparable populations mostly under the traditional fee-for-service model.

Released:
12-Jul-2019 11:05 AM EDT
einstein-monte-logo-cmyk.jpg
  • Embargo expired:
    10-Jul-2019 5:00 PM EDT

Article ID: 715368

Novel Therapy for Acute Migraine Shows Promise in Phase 3 Clinical Trial

Albert Einstein College of Medicine and Montefiore Health System

A drug belonging to a new generation of acute migraine headache treatments was found to eliminate pain and reduce bothersome symptoms for people with migraine in a large-scale trial reported in the July 11 issue of The New England Journal of Medicine. The drug, rimegepant, is awaiting U.S. Food and Drug Administration approval and may offer advantages over currently available migraine medications. The study was led by researchers at Albert Einstein College of Medicine and Montefiore Health System.

Released:
5-Jul-2019 12:40 PM EDT
CUIMC_RGB.jpg
  • Embargo expired:
    26-Jun-2019 5:00 PM EDT

Article ID: 714754

Hidden Consciousness Detectable with EEG Just Days after Brain Injury

Columbia University Irving Medical Center

Nearly 1 in 7 brain-injured patients show early evidence of hidden consciousness—as revealed by EEG analysis—and are more likely to recover, researchers at Columbia have found.

Released:
21-Jun-2019 2:05 PM EDT

Channels:

All Journal News, Neuro, NEJM

Languages:

English

CCHMCLogo.jpg

Article ID: 714441

3 Signs of Progress Against Sickle Cell Disease

Cincinnati Children's Hospital Medical Center

June 19 is World Sickle Cell Awareness Day. Scientists at Cincinnati Children's have recently made three important steps forward in helping people with sickle cell in the U.S. and in sub-Saharan Africa live longer, better lives.

Released:
19-Jun-2019 8:05 AM EDT

Showing results

110 of 332

Chat now!